Current data has a 15-minute delay. Please / to get real-time quotes.
icon

TScan Therapeutics

TCRX

TCRX TScan Therapeutics NASDAQ
Add to watchlist
169.03
0.00 (0.00 %)
At close : Jan 03, 16:00 ET
--
  • Post market
  • 20:00 ET
    Summary
    Options
    Financials
    News
    Filings
    Profile
    TCRX Chart
    See on advanced chart >
    All
    D
    W
    M
    5m
    • Volume 932.67k
    • Turnover 157.90M
    • P/E(TTM) 19.28
    • Turnover % 0.63%
    • P/E(Static) 18.37
    • Market Cap 34.20B
    • P/B 8.13
    • Shares 202.35M
    • 52 Week Range
      166.69
      211.92
    • Day Range
      167.95
      170.40

    About

    TScan Therapeutics, Inc. was incorporated in Delaware on April 17, 2018. The company is a preclinical-stage biopharmaceutical company focused on developing a robust pipeline of T cell receptor-engineered T cell, or TCR-T, therapies for the treatment of...
    • Highlight
      A preclinical-stage biopharmaceutical company that developing T cell receptor engineered T cell therapies for the treatment of cancer
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      07/16/2021
    • Established Date
      04/17/2018
    • Full-time Employees
      154
    • Address
      830 Winter Street Waltham Massachusetts 02451
    • Tel
      1-857-3999500
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App
    All
    QUICK
    Daily
    Weekly
    Monthly
    Minutes
    5 minutes
    15 minutes
    30 minutes
    Ranges
    1 Day
    1 Week
    1 Month
    1 Year
    YTD